The global transcatheter aortic valve implantation market was valued at $4,559 million in 2020, and is estimated to reach $16,937 million by 2030, growing at a CAGR of 14.0% from 2021 to 2030.
Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. This aortic valve replacement can be performed with open heart surgery. Aortic stenosis is a condition where aortic valve cannot open and close properly, this condition can result in breathlessness, chest pain, dizziness, and swollen ankles. And in transcatheter aortic valve implantation an aortic valve to be implanted using a long narrow tube called a catheter. TAVI is more convenient for people who are frail to have a conventional valve replacement. TAVI involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise, due to the increase in prevalence of aortic stenosis.
The growth of the global transcatheter aortic valve implantation (TAVI) market is majorly driven by alarming increase in the prevalence of aortic stenosis, rise in geriatric population, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.
The global Transcatheter Aortic Valve Implantation (TAVI) Market is segmented into procedure and region. By procedure type, the market is categorized into transfemoral procedure, subclavian and othes. Based on region, it is analysed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Switzerland, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and LAMEA (Brazil, Israel, South Africa, Saudi Arabia, and Rest of LAMEA).
Transcatheter aortic valve implantation (TAVI), also called as transcatheter aortic valve replacement (TAVR), is a minimally invasive surgical procedure, which is performed to treat high-risk patients suffering from aortic stenosis. This aortic valve replacement can be performed with open heart surgery. Aortic stenosis is a condition where aortic valve cannot open and close properly, this condition can result in breathlessness, chest pain, dizziness, and swollen ankles. And in transcatheter aortic valve implantation an aortic valve to be implanted using a long narrow tube called a catheter. TAVI is more convenient for people who are frail to have a conventional valve replacement. TAVI involves implantation of transcatheter aortic valves to regenerate the blood circulation ability of the aortic valve. The need of transcatheter aortic valve implantation is on the rise, due to the increase in prevalence of aortic stenosis.
The growth of the global transcatheter aortic valve implantation (TAVI) market is majorly driven by alarming increase in the prevalence of aortic stenosis, rise in geriatric population, advancements in the transcatheter aortic valves and increase in adoption rate of TAVI devices drive the market. However, stringent government regulations for approval of transcatheter aortic valves, which are class III medical devices and high cost associated with TAVI hamper the market growth. Conversely, use of TAVI systems for new indications, rise in healthcare expenditure in emerging economies, and increase in interest of key players in the TAVI market are projected to provide several growth opportunities for the market throughout the forecast period.
The global Transcatheter Aortic Valve Implantation (TAVI) Market is segmented into procedure and region. By procedure type, the market is categorized into transfemoral procedure, subclavian and othes. Based on region, it is analysed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, Switzerland, UK, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), and LAMEA (Brazil, Israel, South Africa, Saudi Arabia, and Rest of LAMEA).
KEY BENEFITS FOR STAKEHOLDERS
- The report provides an in-depth analysis of the global transcatheter aortic valve implantation market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global transcatheter aortic valve implantation market.
KEY MARKET SEGMENTS
By Procedure
- Transfemoral Procedure
- Subclavian Procedure
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Switzerland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Israel
- Saudi Arabia
- South Africa
- Rest of LAMEA
KEY MARKET PLAYERS
- Abbott Laboratories
- Boston Scientific Corporation
- Blue Sail Medical Co.Ltd.
- Bracco
- Edward Lifesciences
- JC Medical Inc.
- JenaValve Techologies Inc.
- Medtronic Plc
- Meril Lifesciences
- Venus Medtech
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: MINIMALLY INVASIVE SURGERY MARKET, BY PROCEDURE
CHAPTER 5: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET, BY REGION
CHAPTER 6: COMPANY PROFILES: TRANSCATHETER AORTIC VALVE IMPLANTATION MARKET
List of Tables
List of Figures
Companies Mentioned
- Abbott Laboratories
- Blue Sail Medical
- Abbott Laboratories
- Blue Sail Medical
- Boston Scientific Corporation
- Bracco
- Edward Life Sciences
- JC Medica
- JenaValve
- Medtronic Plc.
- Meril Life Sciences
- Venus Medtech
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | November 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 4559 million |
| Forecasted Market Value ( USD | $ 16937 million |
| Compound Annual Growth Rate | 14.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
